Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Mar 1;54(5):694-700.
doi: 10.1093/cid/cir896. Epub 2011 Dec 9.

Corticosteroid therapy for liver abscess in chronic granulomatous disease

Affiliations
Case Reports

Corticosteroid therapy for liver abscess in chronic granulomatous disease

Jennifer W Leiding et al. Clin Infect Dis. .

Abstract

Liver abscesses in chronic granulomatous disease (CGD) are typically difficult to treat and often require surgery. We describe 9 X-linked CGD patients with staphylococcal liver abscesses refractory to conventional therapy successfully treated with corticosteroids and antibiotics. Corticosteroids may have a role in treatment of Staphylococcus aureus liver abscesses in CGD.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Computed tomography (CT) and magnetic resonance imaging (MRI) on patient 2. Axial (A) and coronal (B) contrast-enhanced CT images demonstrate a multiseptated abscess within the right lobe of liver measuring 8 cm in maximal craniocaudal dimension (white arrowheads [A]; white arrow [B]). Axial T2 (C) and coronal postgadolinium MRI images (D) with fat saturation obtained 11 months after presentation demonstrate minimal residual T2 signal abnormality (white arrow [C]) and marked reduction in size of the abnormal enhancement within the right lobe of liver (white arrow [D]) now measuring 3.5 cm in diameter.
Figure 2.
Figure 2.
Computed tomography (CT) and magnetic resonance imaging (MRI) on patient 9. Axial (A) and coronal (B) contrast-enhanced CT images demonstrate a multiseptated abscess (white arrowheads [A]; white arrow [B]) within the right hepatic lobe measuring 12.4 cm in maximal craniocaudal dimension. Axial T2-weighted (C) and coronal postgadolinium (D) MRI images with fat saturation obtained 4 months after initial presentation demonstrate minimal residual T2 signal abnormality (white arrow [C]) and marked reduction in the abnormal enhancement within the right lobe of liver (white arrow [D]), now measuring 4.8 cm in aggregate diameter.

References

    1. Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med. 2010;363:2600–10. - PMC - PubMed
    1. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000;79:170–200. - PubMed
    1. Lublin M, Bartlett DL, Danforth DN, et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg. 2002;235:383–91. - PMC - PubMed
    1. Chin TW, Stiehm ER, Falloon J, Gallin JI. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr. 1987;111:349–52. - PubMed
    1. Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462–8. - PubMed

Publication types

Substances